RNA-seq of human MCF10A EditR breast epithelial cells expressing Cas9, with PTBP1 mutation as compared to control
RNA-seq to determine alterations in gene expression and in alternative splicing events in cells where the PTBP1 gene was mutated by CRISPR/Cas9 technology causing resistance to CDC7 kinase inhibitor.